It's worth remembering that only around 25% of patients used it as a combination drug when it was previously marketed. Combination therapy is very expensive and frequently does have side-effects.

123

The fourth quarter numbers are significantly ahead of our forecasts, but there's no pipeline news that we didn't already know.

82